Johnson & Johnson unit Ethicon Endo-Surgery Inc. is asking doctors to return a surgical device used in a now controversial hysterectomy procedure that the U.S. Food and Drug Administration has warned could spread cancerous tissue into a patient’s abdomen, according to Wednesday reports.
Johnson & Johnson said Wednesday that it is executing a worldwide withdrawal of its Morcelex device following a recent meeting with the FDA, which is weighing regulatory actions to reduce the risk of cancer spread during uterine fibroid removal procedures, according to the Associated Press.
Laparoscopic power morcellation, one technique used to treat mostly non-cancerous fibroids, uses a device to break uterine tissue into fragments that can be removed through an incision in the stomach, according to the FDA. Although uterine fibroids are common and usually benign, they may occasionally be cancerous, the agency said. If you or a loved one believes the developed cancer after use of this device please contact Jamie L. Sheller at 1 800 883 2299